Press release
Huntington's Disease Pipeline Outlook Report 2025: Key 20+ Companies and Breakthrough Therapies Shaping the Future Landscape
Request a sample and discover the recent advances in Huntington's Disease Treatment Drugs @ Huntington's Disease Pipeline Outlook Report [https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Huntington's Disease Pipeline Report
* In August 2025, UniQure Biopharma B.V . conducted a study of AMT-130 in patients with early manifest HD and is designed to establish safety and proof-of-concept (PoC). CT-AMT-130-01 is a Phase 1/2, multicenter, first-in-human (FIH) study. The first three cohorts of the study have completed enrollment, including the randomized, double-blind, sham-controlled cohorts. Cohort 4 is open-label.
* In August 2025, Wave Life Sciences Ltd . announced a a Phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of WVE-003 in adult patients with early-manifest HD who carry the targeted single nucleotide polymorphism (SNP) - SNP3.
* DelveInsight's Huntington's Disease pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline therapies for Huntington's Disease treatment.
* The leading Huntington's Disease Companies such as Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG Bio and others.
* Promising Huntington's Disease Pipeline Therapies such as Dimebon, Pridopidine, SAGE-718, Tominersen 60 mg, AB-1001, ISIS 443139 10 mg, ER2001 injection, and others.
Discover groundbreaking developments in Huntington's Disease therapies! Gain in-depth knowledge of key clinical trials, emerging drugs, and market opportunities @ Huntington's Disease Clinical Trials Assessment [https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Huntington's Disease Emerging Drugs Profile
* RG6042: Hoffmann-La Roche
Tominersen (ASO-HTT, RG6042) is an antisense drug in development for the treatment of Huntington's disease. Tominersen is designed to reduce the production of all forms of the huntingtin (HTT) protein, which in its mutated variant (mHTT) is responsible for Huntington's disease. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Huntington's disease.
* PTC518: PTC Therapeutics
PTC518, a small molecule that can be taken orally, reduces the production of the mutated Huntingtin protein that leads to injury and death of the neuron, which results in disease progression. The orally bioavailable small molecule penetrates the blood brain barrier, is selective, titratable, and not effluxed. Currently the drug is in Phase II stage of its clinical trial for the treatment of Huntington's disease.
* ALN-HTT02: Alnylam Pharmaceuticals
ALN-HTT02 is an innovative therapeutic approach for Huntington's disease developed by Alnylam Pharmaceuticals. This drug is a small interfering RNA (siRNA) designed to reduce the production of the huntingtin protein, which is implicated in the disease's pathology. It works by targeting a specific region of the HTT gene's messenger RNA (mRNA), promoting its degradation and thereby preventing the synthesis of both normal and mutant huntingtin proteins. Administered via intrathecal injection. Currently, the drug is in Phase I stage of its clinical trial for the treatment of Huntington's disease.
The Huntington's Disease Pipeline Report Provides Insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Huntington's Disease with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Huntington's Disease Treatment.
* Huntington's Disease Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Huntington's Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Huntington's Disease market
Stay informed about the Huntington's Disease pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Huntington's Disease Unmet Needs [https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Huntington's Disease Companies
Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG Bio and others.
Huntington's Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal
Huntington's Disease Products have been categorized under various Molecule types such as
* Oligonucleotide
* Peptide
* Small molecule
Transform your understanding of the Huntington's Disease Pipeline! See the latest progress in drug development and clinical research @ Huntington's Disease Market Drivers and Barriers, and Future Perspectives [https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Huntington's Disease Pipeline Report
* Coverage- Global
* Huntington's Disease Companies- Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG Bio and others.
* Huntington's Disease Pipeline Therapies- Dimebon, Pridopidine, SAGE-718, Tominersen 60 mg, AB-1001, ISIS 443139 10 mg, ER2001 injection, and others.
* Huntington's Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Huntington's Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay Ahead in Genetic Disorders Research-Access the Full Huntington's Disease Pipeline Analysis Today! @ Huntington's Disease Drugs and Companies [https://www.delveinsight.com/sample-request/huntingtons-disease-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Contents
* Introduction
* Executive Summary
* Huntington's Disease : Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Huntington's Disease - DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* RG6042: Hoffmann-La Roche
* Mid Stage Products (Phase II)
* PTC518: PTC Therapeutics
* Early Stage Products (Phase I)
* ALN-HTT02: Alnylam Pharmaceuticals
* Mid Stage Products (Phase II)
* Preclinical Stage Products
* Drug Name: Company Name
* Inactive Products
* Huntington's Disease - Collaborations Assessment- Licensing / Partnering / Funding
* Huntington's Disease - Unmet Needs
* Huntington's Disease - Market Drivers and Barriers
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=huntingtons-disease-pipeline-outlook-report-2025-key-20-companies-and-breakthrough-therapies-shaping-the-future-landscape]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/huntingtons-disease-pipeline-insight
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Huntington's Disease Pipeline Outlook Report 2025: Key 20+ Companies and Breakthrough Therapies Shaping the Future Landscape here
News-ID: 4148519 • Views: …
More Releases from ABNewswire
Baltimore Immigration Firm Expands Digital Resources Amid Rising USCIS Scrutiny
Baltimore-based Silmi Law launched a digital education initiative for highly skilled immigrants as USCIS approval rates decline sharply. EB-2 NIW approvals dropped from 90% to 43% in FY2024. The firm's platform includes weekly livestreams, case studies, and resources for STEM professionals. Silmi Law maintains a 90% approval rate since 2018 through "Roadmap" consultations that reframe impact narratives around industry adoption rather than credentials, responding to USCIS's heightened scrutiny.
BALTIMORE - Silmi…
Carvina Capital: Apple Scales Back iPhone Air
Apple trims iPhone Air production to protect margins and rebalance supply toward stronger-selling models; investors monitor model mix, pricing discipline, and holiday demand signals across core smartphone lines, while suppliers and analysts assess how reallocation shapes short-term profitability and longer-term strategy.
Image: https://www.abnewswire.com/upload/2025/10/b11099b33b9b713c48f6496e0ff31ff1.jpg
Through the coming quarter Apple reduces planned manufacturing for its ultra-thin iPhone Air and reallocates capacity to higher-demand models, with Carvina Capital focusing on what this means for inventory,…
Your Virtual Office Launches to Deliver Comprehensive Virtual Business Support S …
Oregon-based Your Virtual Office announces its official launch, offering comprehensive virtual office manager services such as professional call answering, project management, and web development to help entrepreneurs focus on growth.
Gresham, OR, USA - October 30, 2025 - Your Virtual Office has officially launched as a new provider of comprehensive virtual office services. The company aims to support entrepreneurs, startups, and remote teams by handling their administrative and operational tasks so…
Startalyst.ai Acquires Halal-Business-Ideas.com to Expand Its Portfolio of Digit …
Startalyst.ai - the AI-powered platform that generates personalized business ideas and startup plans, has officially acquired the domain Halal-Business-Ideas.com [https://halal-business-ideas.com/].
The acquisition expands Startalyst's growing portfolio of digital assets and reinforces its mission to make entrepreneurship more accessible and inclusive across diverse audiences worldwide. The newly acquired domain now permanently redirects visitors to Startalyst's dedicated halal business ideas section, powered by Startalyst's AI generator. The platform helps users instantly create startup…
More Releases for Huntington
AC Company in Huntington Upgrades Emergency Response Capabilities
As temperatures climb and air conditioners are pushed to their limits, many systems begin to fail under strain.
Residents searching for a dependable ac company near me [https://summersphc.com/huntington/] in Huntington, IN, may notice faster response times and improved service delivery this summer. That's because Summers Plumbing Heating & Cooling has invested in enhancing its emergency HVAC response systems to meet the rising demand for rapid cooling solutions during heatwaves and mechanical…
Reliable AC Installation Now Available for Huntington Homeowners
Whether you're upgrading from an outdated unit or installing a brand-new system, having a team that understands your specific needs is key.
When temperatures rise and older systems falter, many homeowners start looking for AC installation near me [https://www.google.com/search?ac+installation+near+me&kgmid=/g/11tp8xn78c] to find the right solution for reliable cooling. In Huntington, a trusted name now offers convenient and professional service that makes the process easier than ever. With its long-standing reputation and customer-first…
Maycon Construction Services: Premier Roofing Solutions in Huntington
Image: https://www.globalnewslines.com/uploads/2025/01/1735918960.jpg
Huntington, NY - Maycon Construction Services is revolutionizing roofing services in Huntington with a commitment to quality, durability, and customer satisfaction. Specializing in Roof Repair Huntington [https://www.google.com/maps?cid=4993935758546148342], the company ensures homes and businesses are protected from leaks, weather damage, and structural issues.
The team at Maycon Construction Services employs state-of-the-art techniques and premium materials to deliver lasting results. Their Roof Replacement Huntington [https://www.google.com/maps/place/Maycon+Construction+Services/@38.4112395,-82.36617,17z/data=!3m1!4b1!4m6!3m5!1s0x8846079778fdc4b5:0x454e061d07439bf6!8m2!3d38.4112395!4d-82.36617!16s%2Fg%2F11sqq7wlm7?authuser=0&hl=en&entry=ttu&g_ep=EgoyMDI0MTIwOC4wIKXMDSoASAFQAw%3D%3D] services are designed to provide an upgrade…
SCHOOL OF ROCK HUNTINGTON READY TO ROCK N’ ROLL
Huntington, NY (November 17, 2016) – School of Rock, the leader in performance-based music education, announces the opening of its newest school in Huntington, New York, located at 145 East Main Street, Huntington, New York 11743. Opening on November 19, the school will host a party from 11 a.m. to 4 p.m., featuring live music from School of Rock students. In addition to the opening party, School of Rock Huntington…
Huntington Beach Real Estate Agent Launches Luxury Home Buying Experience
The Malakai Sparks Group, a Huntington Beach, California-based realty agency spearheaded by president and real estate expert Malakai Sparks, announced the launch of its Huntington Beach Home Buying Experience service, which encompasses “curated experiences” from the entire Malakai Sparks Group team. Designed for the purpose of allowing prospective buyers to take in all Huntington Beach has to offer prior to purchasing a home – while making sure the area is…
Gershow Recycling of Huntington Hosts Customer Appreciation Day
On August 24, Gershow Recycling hosted its Customer Appreciation Day at its Huntington Station facility. Those in attendance received giveaways, enjoyed food, games and the chance to win raffle prizes provided by Gershow and WBAB Radio (102.3 FM), which also provided music for the event.
Gershow has eight locations in Brooklyn, New Hyde Park, Valley Stream, Freeport, Lindenhurst, Huntington Station, Bay Shore and Medford. For more information, call (631) 289-6188…
